The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cabozantinib (Cabo) beyond progression improves survival in advanced renal cell carcinoma patients: The CABEYOND study (Meet-Uro 21).
 
Giuseppe Procopio
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck Sharp & Dohme; Novartis; Pfizer
 
Alessia Mennitto
No Relationships to Disclose
 
Massimo Di Maio
Honoraria - AstraZeneca; Bristol-Myers Squibb; Eisai; Janssen; Mediolanum Farmaceutici; Merck Sharp & Dohme; Pfizer; Takeda
Consulting or Advisory Role - AstraZeneca; Eisai; Janssen; Mediolanum Farmaceutici; Merck Sharp & Dohme; Pfizer; Takeda
Research Funding - Tesaro (Inst)
 
Emma Zattarin
No Relationships to Disclose
 
Marco Maruzzo
No Relationships to Disclose
 
Ugo De Giorgi
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck; MSD; Novartis; Pfizer; PharmaMar; Sanofi
Research Funding - AstraZeneca (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Janssen; Pfizer; Roche
 
Daniele Santini
No Relationships to Disclose
 
Sebastiano Buti
No Relationships to Disclose
 
Chiara Casadei
Travel, Accommodations, Expenses - Ipsen; Pierre Fabre
 
Mariella Soraru'
No Relationships to Disclose
 
Giuseppe Di Lorenzo
No Relationships to Disclose
 
Carlo Messina
No Relationships to Disclose
 
Claudia Mucciarini
No Relationships to Disclose
 
Giandomenico Roviello
No Relationships to Disclose
 
Consuelo Buttigliero
No Relationships to Disclose
 
Marco Stellato
No Relationships to Disclose
 
Pierangela Sepe
No Relationships to Disclose
 
Sandro Pignata
Honoraria - AstraZeneca; MSD; pfizer; pharmamar; Roche; Tesaro
Consulting or Advisory Role - AstraZeneca; Pfizer; PharmaMar; Roche; tesaro
Research Funding - AstraZeneca (Inst); MSD (Inst); Pfizer (Inst); Roche (Inst)
 
Filippo G. De Braud
Honoraria - Bristol-Myers Squibb; Merck; MSD; Pfizer; Roche; Sanofi; SERVIER
Consulting or Advisory Role - Bristol-Myers Squibb; EMD SERONO; Ignyta; Incyte; Nerviano Medical Sciences; Octimet; Pierre Fabre; Roche; Sanofi; Teofarma
Research Funding - Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Ignyta (Inst); Lilly (Inst); Loxo (Inst); MedImmune (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); MSD (Inst); Nektar (Inst); Novartis (Inst); Pfizer (Inst); Philogen (Inst); Roche (Inst); SERVIER (Inst); Tesaro (Inst)
 
Elena Verzoni
Consulting or Advisory Role - Janssen Oncology; Pfizer
Speakers' Bureau - Ipsen; Novartis